BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

5.60

-1.20 (-17.65%)

At close: Aug 13, 2025, 4:00 PM

5.07

-0.53 (-9.46%)

Pre-market: Aug 14, 2025, 9:21 AM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $33.91 million as of August 14, 2025. Its market cap has decreased by -22.77% in one year.

Market Cap

33.91M

Enterprise Value

125.16M

1-Year Change

-22.77%

Ranking

#4723

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $33.91M, a decrease of -80.35%. That is a compound annual growth rate of -19.65%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	33.91M	82.76%
Dec 31, 2024	18.56M	-78.51%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings